These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21901475)

  • 1. Fracture risk assessment in patients with chronic kidney disease.
    Jamal SA; West SL; Miller PD
    Osteoporos Int; 2012 Apr; 23(4):1191-8. PubMed ID: 21901475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mass measurements in men and women with chronic kidney disease.
    Jamal SA
    Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):343-8. PubMed ID: 20414109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of bone architecture and strength in men and women with stage 5 chronic kidney disease.
    West SL; Jamal SA
    Semin Dial; 2012 Jul; 25(4):397-402. PubMed ID: 22686655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to predict and treat increased fracture risk in chronic kidney disease.
    West SL; Patel P; Jamal SA
    J Intern Med; 2015 Jul; 278(1):19-28. PubMed ID: 25758353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture Risk Assessment in Chronic Kidney Disease, Prospective Testing Under Real World Environments (FRACTURE): a prospective study.
    West SL; Lok CE; Jamal SA
    BMC Nephrol; 2010 Aug; 11():17. PubMed ID: 20727179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural approach to skeletal fragility in chronic kidney disease.
    Leonard MB
    Semin Nephrol; 2009 Mar; 29(2):133-43. PubMed ID: 19371804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.
    Yun HJ; Ryoo SR; Kim JE; Choi YJ; Park I; Shin GT; Kim H; Jeong JC
    BMC Nephrol; 2020 Jul; 21(1):299. PubMed ID: 32711466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.
    Marques ID; Araújo MJ; Graciolli FG; Reis LM; Pereira RM; Custódio MR; Jorgetti V; Elias RM; David-Neto E; Moysés RM
    Osteoporos Int; 2017 May; 28(5):1675-1683. PubMed ID: 28204954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of osteoporosis in patients with chronic kidney disease.
    Abdalbary M; Sobh M; Elnagar S; Elhadedy MA; Elshabrawy N; Abdelsalam M; Asadipooya K; Sabry A; Halawa A; El-Husseini A
    Osteoporos Int; 2022 Nov; 33(11):2259-2274. PubMed ID: 35748896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone imaging and fracture risk assessment in kidney disease.
    Jamal SA; Nickolas TL
    Curr Osteoporos Rep; 2015 Jun; 13(3):166-72. PubMed ID: 25744703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fragility fracture in the Chronic Kidney Disease (CKD)].
    Fusaro M; Aghi A; Mereu MC; Giusti A
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease.
    Jamal S; Cheung AM; West S; Lok C
    Osteoporos Int; 2012 Dec; 23(12):2805-13. PubMed ID: 22297732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of dual energy X-ray absorptiometry, the trabecular bone score and quantitative computed tomography in the evaluation of chronic kidney disease-mineral and bone disorders.
    Pocock N
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():19-21. PubMed ID: 28429557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis.
    Jamal SA; Hayden JA; Beyene J
    Am J Kidney Dis; 2007 May; 49(5):674-81. PubMed ID: 17472850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease.
    Jannot M; Mac-Way F; Lapierre V; Lafage-Proust MH
    J Nephrol; 2017 Oct; 30(5):635-643. PubMed ID: 28900872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.
    Aleksova J; Kurniawan S; Elder GJ
    Osteoporos Int; 2018 Jun; 29(6):1447-1455. PubMed ID: 29556678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease and bone fracture: a growing concern.
    Nickolas TL; Leonard MB; Shane E
    Kidney Int; 2008 Sep; 74(6):721-31. PubMed ID: 18563052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rational guide to reducing fracture risk in dialysis patients.
    Toussaint ND; Elder GJ; Kerr PG
    Semin Dial; 2010; 23(1):43-54. PubMed ID: 20331818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY; Chen LR; Chen KH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.